ArticlePhysics and imaging in radiation oncology2026
Real-time tumor tracking for magnetic resonance-guided radiotherapy using label-efficient foundation model adaptation.
Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Purpose: Real-time tumor tracking on cine magnetic resonance imaging (cine-MRI) enables intra-fraction motion management in magnetic resonance-guided radiotherapy. Pipelines often rely on deformable registration or template matching to propagate contours, which can degrade under non-rigid motion and cine-MRI artifacts. This study evaluated two MedSAM2-based adaptations for real-time tracking with limited labels. Materials and Methods: The TrackRAD2025 dataset includes sagittal cine-MRI sequences from six institutions acquired on 0.35 T and 1.5 T MRI-linear accelerators, with 50 labeled and 477 unlabeled training cases and 50 test cases. Tracking was formulated as frame-wise target segmentation from the first-frame ground-truth mask. Method A fine-tuned MedSAM2 on 40 labeled cases and used rank-weighted checkpoint averaging. Method B combined two MedSAM2 models trained on different labeled splits augmented with pseudo-labels, and merged their predictions during inference. Results: On the hidden test set, Method A ranked highest on Dice similarity coefficient (DSC), center distance (CD), 95th-percentile Hausdorff distance (HD95), and mean average surface distance (MASD), with DSC = 0.891, CD = 1.47 mm, HD95 = 4.22 mm, MASD = 1.66 mm, relative dose to 98% of the target volume ( Conclusions: MedSAM2 adaptation enabled real-time cine-MRI tumor tracking with limited labels. The single-model approach provided faster inference and simpler deployment, while semi-supervised ensembling showed no significant improvement at higher computational cost.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.